The performance of companies tied to Sildenafil's history presents a challenging investment scenario . While the initial surge generated substantial gains, generic copies have significantly eroded sales . Investing in connected pharmaceutical businesses now requires a careful assessment of patent safeguards, evolving patient trends , and the prospe